Delivery Order SPE2DR25D3102-SPE2DR26F2R2J
Award Date 2/5/26
Potential Completion Date 2/6/26
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $1,879.48 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for oseltamivir phosphate 75 mg capsules.</p> <p>Place of performance is Conshohocken, PA. The order closes February 6, 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.</p>
- The Defense Logistics Agency issued a $3,813.11 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Oseltamivir Phosphate 75 mg capsules. Place of performance is Conshohocken, PA. The ultimate completion date is February 6, 2026. The order is priced on a firm fixed-price basis with no set-aside. The parent vehicle is an Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026, supporting global pharmaceutical...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for $10,810.85 (ceiling value) under a firm fixed-price contract for Oseltamivir 75 mg, ultimate completion by February 6, 2026.</p> <p>Place of performance is Conshohocken, PA 19428. The order carries no set-aside designation.</p>
- The Defense Logistics Agency awarded a $4,368.70 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. This is a firm fixed price delivery order with a completion date of January 6, 2026, issued under a non-competitive set-aside arrangement. The products will be sourced from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $2,995.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This non-set-aside contract, which will be completed by January 7, 2026, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4,007.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 tablets. This contract, which is non-set-aside and competitively awarded, will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. The delivery order is issued under AmerisourceBergen's parent...
- The Defense Logistics Agency awarded a $2,995.68 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by December 31, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with a ceiling value of $1,408.31. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 22, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent...
- The Defense Logistics Agency awarded a delivery order valued at $1,497.84 to AmerisourceBergen Drug Corp for oseltamivir phosphate 75 mg capsules (unit dose, 10 count) on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen's parent company, Cencora,...
- The Defense Logistics Agency awarded a $7,890.62 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by January 29, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task order against AmerisourceBergen's...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2R2JDelivery Order
The Defense Logistics Agency issued a $2,081.00 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for oseltamivir phosphate 75 mg capsules (unit dose, 10-count). Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of February 6, 2026. No set-aside was used.
Generated 5/6/26, 12:42 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 2/4/26 |